Penserra Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-142
| Closed | -$6K | – | 1580 |
|
|
2021
Q3 | $6K | Buy |
142
+1
| +0.7% | +$42 | ﹤0.01% | 1403 |
|
|
2021
Q2 | $7K | Buy |
141
+1
| +0.7% | +$50 | ﹤0.01% | 1301 |
|
|
2021
Q1 | $10K | Buy |
140
+35
| +33% | +$2.5K | ﹤0.01% | 1037 |
|
|
2020
Q4 | $11K | Buy |
105
+66
| +169% | +$6.91K | ﹤0.01% | 917 |
|
|
2020
Q3 | $3K | Buy |
+39
| New | +$3K | ﹤0.01% | 893 |
|